Fulminant Myocarditis Complicated with Immune Checkpoint Inhibitor in Patients with Thymoma: Report of Three Cases
International Journal of Cardiovascular Practice · 2023
DOI: 10.5812/intjcardiovascpract-130990 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiovascular Practice, 2023. Verfasst von Daozheng Huang und 6 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
: Immune checkpoint inhibitors (ICIs) prevent the immune escape of tumor cells, which helps immune cells such as T lymphocytes to continuously monitor and kill tumor cells, and play powerful anti-tumor role. Immune checkpoint inhibitor-associated myocarditis has been rarely reported; however, its latent, rapidly developed, and lethal onset has gradually attracted the attention of clinicians. This study aimed to report cases of fulminant myocarditis in three patients with thymoma who were treated with pembrolizumab, one of the programmed cell death protein 1 inhibitors (PD-1 inhibitors).
Zitieren
APA
Huang, D., Song, F., Zhang, W., Ma, H., Lin, X., Qin, T., & Wang, S. (2023). Fulminant Myocarditis Complicated with Immune Checkpoint Inhibitor in Patients with Thymoma: Report of Three Cases. International Journal of Cardiovascular Practice. https://doi.org/10.5812/intjcardiovascpract-130990
Vancouver
Huang D, Song F, Zhang W, Ma H, Lin X, Qin T, et al. Fulminant Myocarditis Complicated with Immune Checkpoint Inhibitor in Patients with Thymoma: Report of Three Cases. International Journal of Cardiovascular Practice. 2023. doi:10.5812/intjcardiovascpract-130990
BibTeX
@article{Huang2023,
author = {Huang, Daozheng and Song, Feier and Zhang, Weidai and Ma, Huan and Lin, Xingtao and Qin, Tiehe and Wang, Shouhong},
title = {Fulminant Myocarditis Complicated with Immune Checkpoint Inhibitor in Patients with Thymoma: Report of Three Cases},
journal = {International Journal of Cardiovascular Practice},
year = {2023},
doi = {10.5812/intjcardiovascpract-130990}
}
EUVIMED